Slough, United Kingdom

Philip Anthony Ashworth


Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Philip Anthony Ashworth: A Pioneer in Pharmaceutical Innovations

Introduction

Philip Anthony Ashworth, an inventive mind located in Slough, Great Britain, has made significant contributions to the field of pharmaceuticals. With two patents to his name, he has focused on developing innovative solutions to combat drug resistance, showcasing his commitment to furthering medical science and improving patient outcomes.

Latest Patents

Among his notable patents, Ashworth has developed "Anthranilic acid derivatives as multi-drug resistance modulators" and "Pharmaceutical piperazine compounds." These innovations highlight his expertise in creating compounds that potentially enhance the efficacy of existing treatments against resistant strains of disease.

Career Highlights

Philip Ashworth currently works at Xenova Limited, a firm recognized for its advancements in drug development and research. His role within the company has been pivotal in driving forward-thinking projects that aim to address critical issues in pharmaceuticals.

Collaborations

Throughout his career, Ashworth has collaborated with several accomplished professionals, including Sukhjit Hunjan and Hamish Ryder. These partnerships enable a diverse exchange of ideas and expertise, fostering an environment where innovative solutions can thrive.

Conclusion

In summary, Philip Anthony Ashworth stands as a testament to the power of innovation in the pharmaceutical industry. Through his patents and collaborative spirit, he is paving the way for future advancements that may significantly impact drug treatment options, underscoring the importance of continued research and development in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…